Just a reminder: Is there a place for a more expensive and twice-a-day drug after STEMI pts treated with lytics instead of clopidogrel? No
Ticagrelor Versus Clopidogrel in Patients With STEMI Treated With Fibrinolysis: TREAT Trial.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Mar 2019 – Sep 2022Where it's discussed
-
X / Twitter10 posts
-
News8 articles
-
YouTube2 videos
-
Facebook2 posts
-
Blogs2 articles
AI synopsis
What people are saying
The discussions reflect a cautious interest in the study, with comments like questioning the clinical relevance of alternatives and mentioning the trial's relevance for specific cases like rescue procedures. The tone varies from skeptical to curious, with some posts referencing the study’s findings and implications without deep analysis, indicating a moderate level of engagement and perceived impact.
The posts show varied opinions; some question the clinical significance, while others focus on potential applications.
The discussion demonstrates moderate curiosity, especially regarding the implications for specific patient groups.
Comments reference study details and potential clinical use, indicating a decent level of engagement.
The overall impact appears limited, with the discussion leaning toward curiosity rather than definitive conclusions.
Abstract in brief
- The study aimed to compare the effectiveness of ticagrelor versus clopidogrel in preventing cardiovascular events in patients under 75 who suffered from STEMI and received fibrinolytic therapy.
- Results showed no significant difference in major cardiovascular outcomes between the two medications, with ticagrelor having a 6.7% event rate and clopidogrel 7.3%.
- Overall, ticagrelor did not lead to fewer cardiovascular complications compared to clopidogrel post-treatment in the studied population.
Top posts
Most liked on X and Bluesky@MediCasos Muy buena iniciativa!
Ticagrelor Versus Clopidogrel in Patients With STEMI Treated With Fibrinolysis: TREAT Trial https://t.co/8MY5tz9an0
@AzuSuave https://t.co/HiqnThZvdg Quizás con una n mayor probablemente saldría con una P significativa. Aunque esto fue un estudio de no-inferioridad. No sé si en las próximas guías permitirán el Tica como AAG para FBN. A mi resulta interesante sobre todo para ICP rescate, o ICP precoz.
RT @ISeropianMD: @MediCasos Muy buena iniciativa!
Ticagrelor Versus Clopidogrel in Patients With STEMI Treated With Fibrinolysis: TREAT Trial. - PubMed - NCBI https://t.co/bvY1mFGiQm
All mentions
Key Findings from ACC 2019: Cardiology Insights
This week's episode of 'Café com Journal' summarizes key articles presented at the American College of Cardiology 2019 conference. Key topics include immediate vs. delayed coronary angiography for cardiac arrest…
Advances in Cardiovascular Treatments from Recent Journals
This session reviews key cardiology publications, including sonothrombolysis in STEMI, antiplatelet therapy, LDL reduction, and cardiotoxicity prevention, highlighting recent research and clinical implications for…
Just a reminder: Is there a place for a more expensive and twice-a-day drug after STEMI pts treated with lytics instead of clopidogrel? No
@AzuSuave https://t.co/HiqnThZvdg Quizás con una n mayor probablemente saldría con una P significativa. Aunque esto fue un estudio de no-inferioridad. No sé si en las próximas guías permitirán el Tica como AAG para FBN. A mi resulta interesante sobre todo para ICP rescate, o ICP precoz.
RT @ISeropianMD: @MediCasos Muy buena iniciativa!
RT @ISeropianMD: @MediCasos Muy buena iniciativa!
@MediCasos Muy buena iniciativa!
Ticagrelor Versus Clopidogrel in Patients With STEMI Treated With Fibrinolysis: TREAT Trial. - PubMed - NCBI https://t.co/G5oomjGjLv https://t.co/KYskAtNhAq
Ticagrelor Versus Clopidogrel in Patients With STEMI Treated With Fibrinolysis https://t.co/cZSxWnTmc6
Ticagrelor Versus Clopidogrel in Patients With STEMI Treated With Fibrinolysis: TREAT Trial. - PubMed - NCBI https://t.co/bvY1mFGiQm
Ticagrelor Versus Clopidogrel in Patients With STEMI Treated With Fibrinolysis: TREAT Trial https://t.co/8MY5tz9an0
Ticagrelor Versus Clopidogrel in Patients With STEMI Treated With Fibrinolysis: TREAT Trial - https://t.co/vOsUvVMsxr https://t.co/UdHwaWQYxG
MG
IM
JB
PG
AC
ぽ
NR
EG
AC
D